| P50 | author | Brian Kobilka | Q80907 |
| P2093 | author name string | Dzau VJ | |
| | Pratt RE | |
| | Lawn RM | |
| | Gibbons GH | |
| P2860 | cites work | Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice | Q24315861 |
| | The mysteries of lipoprotein(a) | Q28249594 |
| | cDNA sequence of human apolipoprotein(a) is homologous to plasminogen | Q28302632 |
| | Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q28505210 |
| | Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 |
| | Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat | Q28565054 |
| | Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme | Q28583658 |
| | Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene | Q28592173 |
| | Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 | Q28593256 |
| | Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting | Q29614543 |
| | Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 |
| | Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. | Q33589619 |
| | Expression of murine renin genes in subcutaneous connective tissue | Q33844159 |
| | Renin promoter SV40 T-antigen transgenic mouse. A model of primary renal vascular hyperplasia | Q70178512 |
| | A neuropeptide Y locus on chromosome 4 cosegregates with blood pressure in the spontaneously hypertensive rat | Q70667096 |
| | Proliferation of human smooth muscle cells promoted by lipoprotein(a) | Q70739982 |
| | Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium | Q71599598 |
| | Medical research: progress and promise for the patient. Research! America Forum Consensus Statement | Q72150770 |
| | Gene therapy for cardiovascular disease | Q72270809 |
| | Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes | Q33871566 |
| | Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo | Q33897258 |
| | A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure | Q34172854 |
| | Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice | Q34175241 |
| | Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme | Q34182616 |
| | Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice | Q34229782 |
| | An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels | Q35605274 |
| | Quantitative assessment of atherosclerotic lesions in mice | Q36456167 |
| | Transgenic mouse models of lipoprotein metabolism and atherosclerosis | Q36525382 |
| | Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration | Q36529887 |
| | Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia | Q36534829 |
| | Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells | Q37011453 |
| | Lipoprotein (a). Heterogeneity and biological relevance | Q37853403 |
| | Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit | Q37977688 |
| | Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo | Q38326202 |
| | Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. | Q41164669 |
| | A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure | Q41950805 |
| | Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death | Q43409060 |
| | Restriction fragment length polymorphism of hsp70 gene, localized in the RT1 complex, is associated with hypertension in spontaneously hypertensive rats | Q43523717 |
| | Cadmium block of isometric contractions of isolated bullfrog atrial cells | Q43546552 |
| | Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats | Q44181063 |
| | Ex vivo gene therapy of familial hypercholesterolemia. | Q45083040 |
| | Molecular basis of human hypertension: role of angiotensinogen | Q45118696 |
| | Gene therapy for vascular smooth muscle cell proliferation after arterial injury | Q45871893 |
| | Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits | Q45880751 |
| | Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. | Q46734243 |
| | Atherogenesis in transgenic mice expressing human apolipoprotein(a) | Q46953909 |
| | Tissue and cell specific expression of a renin promoter-reporter gene construct in transgenic mice | Q48933020 |
| | Pluripotent embryonic stem cells from the rat are capable of producing chimeras. | Q52216813 |
| | Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. | Q52229612 |
| | Expression of murine renin genes during fetal development. | Q52242156 |
| | Knockout mice: round two. | Q54200178 |
| | Protein composition determines the anti-atherogenic properties of HDL in transgenic mice | Q59064040 |
| | Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene | Q59066147 |
| | Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo | Q59067674 |
| | Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein | Q59070155 |
| | Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats | Q67526323 |
| | Pathology of atherosclerosis in cholesterol-fed, susceptible mice | Q67800087 |
| | Blood pressure cosegregates with a microsatellite of angiotensin I converting enzyme (ACE) in F2 generation from a cross between original normotensive Wistar-Kyoto rat (WKY) and stroke-prone spontaneously hypertensive rat (SHRSP) | Q68269343 |
| | Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes | Q68426840 |
| | Recombinant gene expression in vivo within endothelial cells of the arterial wall | Q69206990 |
| | Implantation of vascular grafts lined with genetically modified endothelial cells | Q69633337 |
| | Variation in susceptibility to atherosclerosis among inbred strains of mice | Q69805944 |
| | Increased expression of DNA cointroduced with nuclear protein in adult rat liver | Q69937795 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 521-531 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Genetic models of human vascular disease | |
| P478 | volume | 91 | |